Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthew C Pickering

Showing results (11-20 of 137) with videos related to

Pageof 14
Sort By:
Seminars in Nephrology|October 29, 2013
Dense deposit disease and C3 glomerulopathyThomas D Barbour, Matthew C Pickering, H Terence Cook
Nature Reviews. Rheumatology|August 11, 2017
The complement system as a potential therapeutic target in rheumatic diseaseLeendert A Trouw, Matthew C Pickering, Anna M Blom
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|October 19, 2014
Update on C3 glomerulopathyThomas D Barbour, Marieta M Ruseva, Matthew C Pickering
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|March 13, 2013
Recent insights into C3 glomerulopathyThomas D Barbour, Matthew C Pickering, H Terence Cook
Seminars in Immunopathology|August 11, 2021
Complement activation in IgA nephropathyNicholas R Medjeral-Thomas, H Terence Cook, Matthew C Pickering
Current Opinion in Nephrology and Hypertension|March 26, 2021
Complement and kidney disease, new insightsNicholas R Medjeral-Thomas, Matthew C Pickering, H Terence Cook
Molecular Immunology|May 24, 2011
Dense deposit diseaseRichard J H Smith, Claire L Harris, Matthew C Pickering
Rheumatology International|February 18, 2011
Painful myositis in the anti-synthetase syndrome with anti-PL12 antibodiesPuja Mehta, Leena Patel, Federico Roncaroli, et al.
Practical Neurology|February 14, 2018
Autoimmune necrotising myopathy and HMGCR antibodiesKushan Karunaratne, Dimitri Amiras, Matthew C Pickering, et al.
Pediatric Nephrology (Berlin, Germany)|February 19, 2026
Complement and kidney diseases: unlocking the opportunity of targeted treatments for glomerular diseases, including IgA nephropathyJoshua Wade, David C Thomas, Matthew C Pickering, et al.
Pageof 14

Showing results (11-20 of 137) with videos related to

Sort By:
Pageof 14
Seminars in Nephrology|October 29, 2013
Dense deposit disease and C3 glomerulopathyThomas D Barbour, Matthew C Pickering, H Terence Cook
Nature Reviews. Rheumatology|August 11, 2017
The complement system as a potential therapeutic target in rheumatic diseaseLeendert A Trouw, Matthew C Pickering, Anna M Blom
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|October 19, 2014
Update on C3 glomerulopathyThomas D Barbour, Marieta M Ruseva, Matthew C Pickering
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|March 13, 2013
Recent insights into C3 glomerulopathyThomas D Barbour, Matthew C Pickering, H Terence Cook
Seminars in Immunopathology|August 11, 2021
Complement activation in IgA nephropathyNicholas R Medjeral-Thomas, H Terence Cook, Matthew C Pickering
Current Opinion in Nephrology and Hypertension|March 26, 2021
Complement and kidney disease, new insightsNicholas R Medjeral-Thomas, Matthew C Pickering, H Terence Cook
Molecular Immunology|May 24, 2011
Dense deposit diseaseRichard J H Smith, Claire L Harris, Matthew C Pickering
Rheumatology International|February 18, 2011
Painful myositis in the anti-synthetase syndrome with anti-PL12 antibodiesPuja Mehta, Leena Patel, Federico Roncaroli, et al.
Practical Neurology|February 14, 2018
Autoimmune necrotising myopathy and HMGCR antibodiesKushan Karunaratne, Dimitri Amiras, Matthew C Pickering, et al.
Pediatric Nephrology (Berlin, Germany)|February 19, 2026
Complement and kidney diseases: unlocking the opportunity of targeted treatments for glomerular diseases, including IgA nephropathyJoshua Wade, David C Thomas, Matthew C Pickering, et al.
Pageof 14